Leo presents new strategy: doubles research investment

Leo Pharma’s strategy for the next seven years is ready and it involves a massive upgrade of the research in well-known as well as new disease areas. However, this also means decreasing financial results for the company in the years to come.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Related articles